Published:
Aduromed Announces New CEO; Completes New Equity Capital Raise of $4.8 Million
BETHEL, Conn., Sept. 3 /PRNewswire-FirstCall/ -- Aduromed Industries, Inc.
(OTC Bulletin Board: ADRM), a provider of innovative technology and services
for the onsite treatment and disposal of regulated medical waste, today
announced the appointment of Mr. Scott Grisanti as President and Chief
Executive Officer of the Company. Mr. Grisanti was also elected as a director
of the Company. The Company also announced the raising of an additional
$1 million of new equity capital pursuant to its previously announced
corporate restructuring. This brings the total amount of new equity capital
raised pursuant to the restructuring to $4.8 million after placement fees.
Prior to joining the Company, Mr. Grisanti was the Executive Vice
President of Sales, Marketing and Services at Primavera Systems, Inc., a
leading provider of program and portfolio management application software and
services solutions used to manage large capital projects in targeted market
segments. He led the effort to increase revenues from $108 million to $205
million projected for 2008. Prior to joining Primavera, Grisanti served as
Executive Vice President and Chief Marketing Officer for eResearchTechnology,
Inc., a leading provider of technology and services for the new drug
development industry. Responsible for global sales, marketing and strategic
alliances, he was a key member of an executive team that increased revenues
from $28 million to $109 million and market capitalization from $42 million to
$1.5 billion. Previously, Grisanti served in an executive sales management
capacity at supply chain execution application solution providers ClearCross,
Inc. and Optum, Inc. He received his bachelor degree in English and Journalism
from Rutgers University, where he was elected to Phi Beta Kappa.
Mr. Joseph Esposito, Chairman of the Company, commented, "I have known and
worked with Scott for many years and I am confident that Scott brings
exceptional leadership experience to the executive management team and the
board. He possesses a unique blend of business development skills and
operational experience that will enable him to execute the Company's plan to
accelerate growth at this stage in its development. I welcome Scott to the
Aduromed team and look forward to once again working with him."
"I am excited to have the opportunity to again partner with Joe, as well
as the entire Aduromed team, to create significant shareholder value as we
execute our plan to accelerate growth at Aduromed," said Mr. Grisanti. "My
immediate focus will be to expand the product line, offering standard systems
with flexible acquisition alternatives to a broader base of potential clients.
In addition, we will be adding talent to the management team to enable us to
expand our regulatory service business and expand our market footprint through
complementary channels of distribution."
About Aduromed
Aduromed Industries, Inc., through its wholly-owned subsidiary, Aduromed
Corporation, is a provider of innovative technology and services for the
onsite treatment and disposal of regulated medical waste. Aduromed's flagship
MedClean(R) Series systems are fully integrated, turnkey technology solutions
that enable hospitals and other healthcare providers to safely, efficiently
and cost-effectively convert bio-hazardous regulated medical waste into
sterile, unrecognizable material suitable for disposal as municipal solid
waste.
Aduromed was founded in 1997 with corporate headquarters, research and
development and distribution facilities located inBethel, Connecticut.
Further information on Aduromed can be found at http://www.aduromed.com and in
filings with the Securities and Exchange Commission found at
http://www.sec.gov.
Statements about our future expectations are "forward-looking statements"
within the meaning of applicable Federal Securities Laws, and are not
guarantees of future performance. When used herein, the words "may," "will,"
"should," "anticipate," "believe," "appear," "intend," "plan," "expect,"
"estimate," "approximate," and similar expressions are intended to identify
such forward-looking statements. These statements involve risks and
uncertainties inherent in our business, including those set forth in our most
recent Annual Report on Form 10-K for the year ended December 31, 2007, filed
with the SEC on March 31, 2008, and other filings with the SEC, and are
subject to change at any time. Our actual results could differ materially from
these forward-looking statements. We undertake no obligation to update
publicly any forward-looking statement.
SOURCE Aduromed Industries, Inc.
Copyright © 2008, PRNewswire
Copyright © 2008, NewsBlaze,
Daily NewsTags: ,HEA,MTC,CPR,OTC,PER,CT-Aduromed-New-CEO
_ _Is your favorite bookmark site missing?
Ask for it.
Search News
Daily News
